AUC for serial assessments | Persistent-patients (n = 32) | Nonpersistent patients (n = 43) | P value |
---|---|---|---|
Clinical | |||
Disease activity score (28 joints) | 2.83 ± 1.45 | 3.04 ± 0.89 | 0.45 |
66 swollen joint counts | 3.65 ± 5.06 | 3.99 ± 2.86 | 0.72 |
68 tender joint counts | 4.02 ± 5.16 | 3.94 ± 2.74 | 0.94 |
Physician global assessment of disease activity visual analogue scale | 11.72 ± 16.46 | 12.24 ± 7.60 | 0.87 |
Patient pain visual analogue scale | 11.79 ± 11.42 | 12.77 ± 7.24 | 0.65 |
Patient overall disease visual analogue scale | 11.73 ± 12.3 | 13.19 ± 7.26 | 0.52 |
Health assessment questionnaire | 0.23 ± 0.36 | 0.36 ± 0.32 | 0.23 |
Serological | |||
Erythrocyte sedimentation rate | 16.99 ± 11.97 | 15.99 ± 9.67 | 0.69 |
C-reactive protein | 1.18 ± 1.52 | 0.73 ± 0.69 | 0.13 |
Number of comorbidities/patient | 1.33 ± 2.4 | 1.1 ± 1.48 | 0.62 |
Treatment | |||
Number of DMARDs/patient | 2.31 ± 0.71 | 2.47 ± 0.71 | 0.35 |
Number of drugs for comorbidity/patient | 1.81 ± 1.03 | 1.83 ± 0.88 | 0.90 |
Number of total drugs/patient | 4.38 ± 1.13 | 4.61 ± 1.17 | 0.39 |